ArticleBMC pulmonary medicine2026
Complementary assessment of cardiopulmonary morphometric changes in COPD using 3D multidetector computed tomography: relationship with functional indices.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to quantitatively evaluate the structural remodeling of cardiopulmonary tissues in Chronic Obstructive Pulmonary Disease (COPD) using three-dimensional multidetector computed tomography (3D-MDCT) and to investigate the relationship between these morphometric changes and functional disease severity across genders.
methodsA retrospective analysis was performed on 114 participants (58 stable COPD patients and 56 age-matched controls). Pulmonary function tests (PFT), Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging, and clinical scores (CAT, mMRC) were recorded. Right/left lung volumes (RLV, LLV) and heart ventricular volumes (RV, LV) were measured via 3D-Slicer software. Major vascular diameters (VCS, VCI, PA) were assessed on axial CT sections.
resultsDistinct gender-related structural patterns were identified. Male COPD patients exhibited significantly higher right lung volumes compared to controls (p < 0.01), which showed a strong negative correlation with the Forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio, indicating hyperinflation-driven remodeling. Conversely, male patients demonstrated significantly lower right heart ventricular volumes (RV) (p < 0.05), supporting the “pseudomicrocardia” effect where hyperinflation mechanically restricts cardiac filling. In female COPD patients, pulmonary artery (PA) diameters were higher than in controls, showing a borderline significant trend (p = 0.050), while total lung volume negatively correlated with Vena Cava Superior (VCS) diameter (p < 0.05). Across both genders, smoking pack-years were identified as a significant independent predictor of increased total lung volume (p < 0.05). Although morphometric parameters did not differ significantly across GOLD stages, RV volume was notably increased in the GOLD E subgroup, reflecting higher symptom burden.
conclusions3D-MDCT provides a quantitative and objective assessment of secondary cardiopulmonary structural changes that may accompany COPD. The study suggests a potential gender dimorphism in structural remodeling; while hyperinflation-related cardiac compression (pseudomicrocardia) appears more notable in males, vascular alteration trends seem more prominent in females. These morphometric insights may serve as a valuable complementary tool to spirometry, especially in monitoring disease progression and evaluating systemic structural effects in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.